retatrutide clinical trial brazil Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss and A1c reduction in people A new clinical trial from

Beyond nausea, the gastrointestinal side effect cluster includes diarrhea, vomiting, constipation, and decreased appetite, which is technically a desired effect but can become problematic at extreme levels

Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Wegovy

We prescribe in medications 4-week increments, so you can take it one step at a time

The COR-I trial, involving 1,742 participants over 56 weeks, demonstrated 6.1% average weight loss with Contrave versus 1.3% with placebo (Greenway et al., Obesity, 2010)

Long-term changes in cardiac structure and function following bariatric surgery

The MHRA dismantled UK-based illicit manufacturing operations producing fake retatrutide and tirzepatide pens in October 2025 and February 2026